{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:24Z","timestamp":1761514404775,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572253","81702258"],"award-info":[{"award-number":["81572253","81702258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017YFA0505501"],"award-info":[{"award-number":["2017YFA0505501"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Paramount Importance Subject","award":["2017ZZ02025"],"award-info":[{"award-number":["2017ZZ02025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00432-019-02952-w","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T15:02:36Z","timestamp":1559919756000},"page":"2115-2122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy"],"prefix":"10.1007","volume":"145","author":[{"given":"Han","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Difan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqiu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zitong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1305-971X","authenticated-orcid":false,"given":"Haiquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"2952_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(10)60059-1","volume":"375","author":"R Arriagada","year":"2010","unstructured":"Arriagada R et al (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (London, England) 375:1267\u20131277. \n                              https:\/\/doi.org\/10.1016\/s0140-6736(10)60059-1","journal-title":"Lancet (London, England)"},{"key":"2952_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. \n                              https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"2952_CR3","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.jtho.2018.08.2021","volume":"13","author":"W Deng","year":"2018","unstructured":"Deng W et al (2018) Survival patterns for patients with resected N2 Non-small cell lung cancer and postoperative radiotherapy: a prognostic scoring model and heat map approach. J Thorac Oncol 13:1968\u20131974. \n                              https:\/\/doi.org\/10.1016\/j.jtho.2018.08.2021","journal-title":"J Thorac Oncol"},{"key":"2952_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P et al (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39\u201351. \n                              https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"2952_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/sim.981","volume":"21","author":"S Keles","year":"2002","unstructured":"Keles S, Segal MR (2002) Residual-based tree-structured survival analysis. Stat Med 21:313\u2013326","journal-title":"Stat Med"},{"key":"2952_CR6","doi-asserted-by":"publisher","unstructured":"Liu S et al. (2016) Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol 34:307\u2013313 \n                              https:\/\/doi.org\/10.1200\/jco.2015.63.4907\n                              \n                           . \n                              https:\/\/doi.org\/10.1200\/jco.2016.34.2_suppl.307","DOI":"10.1200\/jco.2015.63.4907 10.1200\/jco.2016.34.2_suppl.307"},{"key":"2952_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.athoracsur.2012.01.065","volume":"93","author":"CE Nwogu","year":"2012","unstructured":"Nwogu CE et al (2012) Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg 93:1614\u20131619. \n                              https:\/\/doi.org\/10.1016\/j.athoracsur.2012.01.065\n                              \n                           \n                           (discussion 1619\u20131620)","journal-title":"Ann Thorac Surg"},{"key":"2952_CR8","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE et al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv1\u2013iv21. \n                              https:\/\/doi.org\/10.1093\/annonc\/mdx222","journal-title":"Ann Oncol"},{"key":"2952_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/JTO.0b013e3182829c16","volume":"8","author":"C Qiu","year":"2013","unstructured":"Qiu C, Dong W, Su B, Liu Q, Du J (2013) The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer. J Thorac Oncol 8:429\u2013435. \n                              https:\/\/doi.org\/10.1097\/JTO.0b013e3182829c16","journal-title":"J Thorac Oncol"},{"key":"2952_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/JTO.0b013e3181a0d82e","volume":"4","author":"VW Rusch","year":"2009","unstructured":"Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4:568\u2013577. \n                              https:\/\/doi.org\/10.1097\/JTO.0b013e3181a0d82e","journal-title":"J Thorac Oncol"},{"key":"2952_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.athoracsur.2013.04.031","volume":"96","author":"MD Taylor","year":"2013","unstructured":"Taylor MD et al (2013) Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer. Ann Thorac Surg 96:1163\u20131170. \n                              https:\/\/doi.org\/10.1016\/j.athoracsur.2013.04.031","journal-title":"Ann Thorac Surg"},{"key":"2952_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/JTO.0b013e318292c53e","volume":"8","author":"D Urban","year":"2013","unstructured":"Urban D, Bar J, Solomon B, Ball D (2013) Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer. J Thorac Oncol 8:940\u2013946. \n                              https:\/\/doi.org\/10.1097\/JTO.0b013e318292c53e","journal-title":"J Thorac Oncol"},{"key":"2952_CR13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","volume":"28","author":"VW Wong","year":"2010","unstructured":"Wong VW et al (2010) Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol 28:1660\u20131665. \n                              https:\/\/doi.org\/10.1200\/jco.2009.26.2675","journal-title":"J Clin Oncol"},{"key":"2952_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jtho.2017.03.017","volume":"12","author":"M Xi","year":"2017","unstructured":"Xi M et al (2017) A prognostic scoring model for the utility of induction chemotherapy prior to neoadjuvant chemoradiotherapy in esophageal cancer. J Thorac Oncol 12:1001\u20131010. \n                              https:\/\/doi.org\/10.1016\/j.jtho.2017.03.017","journal-title":"J Thorac Oncol"},{"key":"2952_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2016.11.053","volume":"153","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Li G, Zheng D, Jia M, Dai W, Sun Y, Chen H (2017) The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma. J Thorac Cardiovasc Surg 153:702\u2013709.e701. \n                              https:\/\/doi.org\/10.1016\/j.jtcvs.2016.11.053","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2952_CR16","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.jtcvs.2017.10.075","volume":"155","author":"D Zheng","year":"2018","unstructured":"Zheng D, Ye T, Hu H, Zhang Y, Sun Y, Xiang J, Chen H (2018) Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg 155:1814\u20131822.e1814. \n                              https:\/\/doi.org\/10.1016\/j.jtcvs.2017.10.075","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02952-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:21:11Z","timestamp":1591399271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02952-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02952-w","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Han Han declares that he has no conflict of interest. Yue Zhao declares that he has no conflict of interest. Zhendong Gao declares that he has no conflict of interest. Difan Zheng declares that he has no conflict of interest. Fangqiu Fu declares that he has no conflict of interest. Zitong Zhao declares that he has no conflict of interest. Ya Tang declares that he has no conflict of interest. Jiaqing Xiang declares that he has no conflict of interest. Yihua Sun declares that he has no conflict of interest. Hong Hu declares that he has no conflict of interest. Haiquan Chen declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}